STOCK TITAN

WisdomTree (WT) Financials

WT NYSE
Trailing 12 months to June 30, 2026
Revenue $609.7M +37.1% YoY
Net Income $80.9M +12.0% YoY
EPS (Diluted) $0.52 +36.8% YoY
Free Cash Flow $195.9M +53.9% YoY
Market Cap $3.3B as of Oct 29, 2026
Price / Sales 5.4x on $609.7M revenue, trailing 12 months to June 30, 2026
Price / Earnings 40.4x on $80.9M net income, trailing 12 months to June 30, 2026
Price / Book 7.8x on $418.5M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WT SEC filings page.

WisdomTree, Inc. (WT) reported $609.7M in revenue over the twelve months to Jun 30, 2026, up 37.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WT FY2025

WisdomTree’s cash-generating model is expanding margins, but recent growth has increasingly relied on debt rather than equity.

FY2025 free cash flow was $148M against net income of $109M, a cash outcome that exceeded the accounting result rather than merely mirroring it. Capital expenditures were only $215K, so the gap reflects a light reinvestment burden consistent with an asset-light operating model.

The balance-sheet shift is financing, not just scale: long-term debt rose 192.6% from FY2023 to FY2025, while equity changed only 1.1%. The current ratio fell from 2.2x to 1.7x, showing less short-term cushion as liabilities took a larger role in funding growth.

The operating model is gaining efficiency: revenue grew 15.4% in FY2025 while SG&A rose 6.2%, so overhead absorbed a smaller share of growth. Operating margin expanded 3.2 percentage points to 35.3%, indicating that incremental scale reached operating profit rather than being consumed by administration.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 68 / 100
Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of WisdomTree, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
88

WisdomTree, Inc. has an operating margin of 35.3%, meaning the company retains $35 of operating profit per $100 of revenue. This strong profitability earns a score of 88/100, reflecting efficient cost management and pricing power. This is up from 32.1% the prior year.

Growth
80

WisdomTree, Inc.'s revenue surged 15.4% year-over-year to $493.8M, reflecting rapid business expansion. This strong growth earns a score of 80/100.

Leverage
22

WisdomTree, Inc. has elevated debt relative to equity (D/E of 1.94), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 22/100, reflecting increased financial risk.

Liquidity
51

WisdomTree, Inc.'s current ratio of 1.75 indicates adequate short-term liquidity, earning a score of 51/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
93

WisdomTree, Inc. converts 29.9% of revenue into free cash flow ($147.7M). This strong cash generation earns a score of 93/100.

Returns
75

WisdomTree, Inc. earns a strong 26.4% return on equity (ROE), meaning it generates $26 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is up from 16.7% the prior year.

Altman Z-Score Grey Zone
2.86

WisdomTree, Inc. scores 2.86, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $3.3B against total liabilities of $1.1B. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

WisdomTree, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Cash-Backed
1.36x

For every $1 of reported earnings, WisdomTree, Inc. generates $1.36 in operating cash flow ($147.9M OCF vs $109.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
97.81x

WisdomTree, Inc. earns $97.81 in operating income for every $1 of interest expense ($174.2M vs $1.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$177.2M
YoY+57.3%
QoQ+11.1%

WisdomTree, Inc. generated $177.2M in revenue in Q2 2026. This represents an increase of 57.3% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

EBITDA
$75.2M
YoY+113.6%
QoQ+22.4%

WisdomTree, Inc.'s EBITDA was $75.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 113.6% from the same quarter a year earlier. Against the prior quarter it is up 22.4%.

Net Income
$44.3M
YoY+78.7%
QoQn/m

WisdomTree, Inc. reported $44.3M in net income in Q2 2026. This represents an increase of 78.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
$0.28
YoY+64.7%
QoQn/m

WisdomTree, Inc. earned $0.28 per diluted share (EPS) in Q2 2026. This represents an increase of 64.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
$75.3M
YoY+94.5%
QoQ+320.1%
5Y CAGR+30.3%
10Y CAGR+13.1%

WisdomTree, Inc. generated $75.3M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 94.5% from the same quarter a year earlier. Against the prior quarter it is up 320.1%.

Cash & Debt
$294.8M
YoY+52.2%
QoQ-52.9%
5Y CAGR+12.0%
10Y CAGR+5.4%

WisdomTree, Inc. held $294.8M in cash against $1.1B in long-term debt as of Q2 2026.

Dividends Per Share
$0.03
YoY0.0%
QoQ0.0%

WisdomTree, Inc. paid $0.03 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
152M
YoY+3.0%
QoQ-0.9%

WisdomTree, Inc. had 152M shares outstanding in Q2 2026. This represents an increase of 3.0% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Margins & Returns

Operating Margin
40.5%
YoY+9.8pp
QoQ+3.3pp

WisdomTree, Inc.'s operating margin was 40.5% in Q2 2026, reflecting core business profitability. This is up 9.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.3 percentage points.

Net Margin
25.0%
YoY+3.0pp
QoQ+39.5pp

WisdomTree, Inc.'s net profit margin was 25.0% in Q2 2026, showing the share of revenue converted to profit. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 39.5 percentage points.

Return on Equity
10.6%
YoY+5.0pp
QoQ+15.4pp

WisdomTree, Inc.'s quarterly ROE was 10.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.4 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$25.9M
YoYn/m
QoQ+3.9%
5Y CAGR-4.0%
10Y CAGR+74.5%

WisdomTree, Inc. spent $25.9M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 3.9%.

Capital Expenditures
$188K
YoY+118.6%
QoQ+571.4%
5Y CAGR+21.8%
10Y CAGR-3.3%

WisdomTree, Inc. invested $188K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 118.6% from the same quarter a year earlier. Against the prior quarter it is up 571.4%.

R&D Spending

Not reported for Q2 2026.

WT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WT quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$177.2M+57.3%$159.5M+47.5%$147.4M+33.2%$125.6M+11.0%$112.6M+5.2%$108.1M+11.6%$110.7M+21.9%$113.2M+25.2%
SG&A Expenses$30.2M+42.2%$24.9M+20.1%$24.8M+8.6%$22.4M+6.4%$21.3M+5.5%$20.7M+3.8%$22.9M$21.0M+16.5%
Operating Income$71.8M+107.4%$59.4M+73.7%$59.7M+70.5%$45.7M+11.9%$34.6M+3.3%$34.2M+22.2%$35.0M+34.6%$40.8M+52.8%
EBITDA$75.2M+113.6%$61.4M+77.1%$61.8M+73.8%$46.3M+12.2%$35.2M+3.8%$34.7M+22.5%$35.5M+34.8%$41.2M+52.7%
Interest Expense$242K-48.3%$235K-48.4%-$7.6Mn/m$8.5M+95.5%$468K-86.5%$455K-31.7%-$5.8Mn/m$4.3M+25.1%
Income Tax$14.3M+101.1%$8.5M+49.0%$10.4M+51.5%$9.8M+17.5%$7.1M-8.7%$5.7M+0.7%$6.9M+21.1%$8.4M+43.1%
Net Income$44.3M+78.7%-$23.1M-193.9%$40.0M+46.6%$19.7Mn/m$24.8M+13.9%$24.6M+11.4%$27.3M+43.1%-$4.5M-134.5%
EPS (Basic)$0.30+76.5%-$0.17-200.0%$0.29+61.1%$0.14$0.17+30.8%$0.17+21.4%$0.18-$0.13
EPS (Diluted)$0.28+64.7%-$0.17-200.0%$0.28+64.7%$0.13$0.17+30.8%$0.17+30.8%$0.17-$0.13
Diluted Shares (Avg)156M+6.6%138M-5.8%N/A151M147M-11.9%147M-11.3%N/A144M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

WT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WT quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$1.6B+54.2%$1.8B+74.4%$1.5B+46.4%$1.4B+41.9%$1.1B+10.7%$1.0B+9.8%$1.0B+9.5%$1.0B+7.1%
Current Assets$423.4M+20.7%$768.1M+145.0%$492.4M+54.6%$716.4M+133.2%$350.7M+37.7%$313.5M+40.6%$318.4M+38.5%$307.2M+45.0%
Cash & Equivalents$294.8M+52.2%$625.5M+267.1%$311.7M+72.0%$555.9M+215.0%$193.7M+46.2%$170.4M+45.7%$181.2M+40.1%$176.5M+97.2%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$74.8M+73.8%$66.1M+43.3%$64.5M+43.7%$46.6M$43.1M+1.0%$46.1M+15.3%$44.9M+26.5%N/A
Long-Term Investments$0n/m$0n/m$0-100.0%$0-100.0%$0-100.0%$0-100.0%$206K-10.4%$212K-10.5%
Goodwill$355.4M+309.3%$228.6M+163.3%$228.6M+163.3%$86.8M0.0%$86.8M0.0%$86.8M0.0%$86.8M0.0%$86.8M0.0%
Total Liabilities$1.2B+97.3%$1.3B+115.5%$1.1B+73.5%$1.1B+66.6%$621.8M+61.1%$607.2M+61.6%$633.6M+57.4%$644.5M+84.2%
Current Liabilities$141.4M-42.0%$168.1M+105.4%$282.1M+158.3%$254.4M+139.0%$243.9M+187.9%$81.9M+8.3%$109.2M+5.8%$106.5M+41.3%
Non-Current Liabilities$1.1B+187.2%$1.1B+117.1%$817.2M+55.8%$819.2M+52.2%$377.9M+25.4%$525.4M+75.0%$524.4M+75.2%$538.0M+96.0%
Long-Term Debt$1.1B+190.5%$1.1B+119.5%$804.2M+57.1%$805.1M+57.4%$364.1M+32.1%$512.7M+86.2%$512.0M+86.3%$511.4M+86.3%
Total Equity$418.5M-6.0%$475.0M+14.3%$413.7M+3.4%$373.4M-0.4%$445.1M-0.1%$415.6M-1.8%$400.0M-2.2%$374.9M-20.1%
Retained Earnings$233.3M+36.9%$193.4M+28.9%$220.8M+70.1%$185.0M+73.0%$170.4M+31.5%$150.0M+32.9%$129.8M+35.6%$106.9M+30.4%

Not reported in any period shown, so not listed: Inventory.

WT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WT quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$75.5M+94.6%$18.0M+181.9%$54.7M+58.2%$48.1M+0.8%$38.8M+20.5%$6.4Mn/m$34.6M-7.2%$47.7M+68.5%
Depreciation & Amortization$3.4M+488.8%$2.1M+288.1%$2.0M+305.4%$615K+37.6%$580K+38.8%$540K+41.0%$504K+50.4%$447K+45.6%
Stock-Based Compensation$7.8M+40.7%$8.4M+35.2%N/A$4.9M-6.1%$5.5M-1.2%$6.2M+20.8%N/A$5.2M+32.7%
Capital Expenditures$188K+118.6%$28K-9.7%$61K+369.2%$37K+42.3%$86K+138.9%$31K-53.0%$13K-35.0%$26K-25.7%
Free Cash Flow$75.3M+94.5%$17.9M+182.8%$54.6M+58.1%$48.0M+0.7%$38.7M+20.3%$6.3Mn/m$34.6M-7.2%$47.7M+68.6%
Investing Cash Flow-$168.1Mn/m$38.6Mn/m-$276.9Mn/m-$19.5Mn/m-$16.5Mn/m-$214K-110.6%-$7.0M-115.1%-$7.2Mn/m
Financing Cash Flow-$237.7Mn/m$258.8Mn/m-$21.5Mn/m$334.8M+44304.5%-$4.3Mn/m-$19.2Mn/m-$19.1Mn/m$754Kn/m
Dividends Paid$4.3M-0.4%$4.7M+2.6%$4.1M-3.9%$4.3M-11.8%$4.3M-11.9%$4.6M-7.4%$4.3M-18.9%$4.9M-7.2%
Share Buybacks$25.9Mn/m$25.0M+96.3%$0n/m$90.0M+63.5%$0n/m$12.7M+62.6%$0n/m$55.0M+183400.0%

WT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WT quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Margin40.5%+9.8pp37.2%+5.6pp40.5%+8.9pp36.3%+0.3pp30.8%-0.6pp31.6%+2.7pp31.6%+3.0pp36.0%+6.5pp
Net Margin25.0%+3.0pp-14.5%-37.3pp27.2%+2.5pp15.7%+19.6pp22.0%+1.7pp22.8%0.0pp24.7%+3.7pp-4.0%-18.3pp
Return on Equity10.6%+5.0pp-4.9%-10.8pp9.7%+2.8pp5.3%+6.5pp5.6%+0.7pp5.9%+0.7pp6.8%+2.2pp-1.2%-4.0pp
Return on Assets2.7%+0.4pp-1.3%-3.7pp2.6%0.0pp1.4%+1.8pp2.3%+0.1pp2.4%0.0pp2.6%+0.6pp-0.4%-1.8pp
Current Ratio3.00+1.6x4.57+0.7x1.75-1.2x2.82-0.1x1.44-1.6x3.83+0.9x2.92+0.7x2.88+0.1x
Debt-to-Equity2.53+1.7x2.37+1.1x1.94+0.7x2.16+0.8x0.82+0.2x1.23+0.6x1.28+0.6x1.36+0.8x
Liabilities-to-Equity2.93+1.5x2.76+1.3x2.66+1.1x2.88+1.2x1.40+0.5x1.46+0.6x1.58+0.6x1.72+1.0x
Asset Turnover0.110.0x0.090.0x0.100.0x0.090.0x0.110.0x0.110.0x0.110.0x0.110.0x
FCF Margin42.5%+8.1pp11.2%+5.4pp37.0%+5.8pp38.3%-3.9pp34.4%+4.3pp5.9%+7.0pp31.2%-9.8pp42.1%+10.9pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
WisdomTree, Inc. WT FY2025 $493.8M $109.1M 22.1% $3.3B 68/100
GCM Grosvenor Inc. GCMG FY2025 $557.6M $45.4M 8.1% $2.6B 67/100
Brookfield Business Corporation BBUC FY2025 $27.5B $387.0M 1.4% $5.9B 30/100
Patria Investments Limited PAX FY2025 $381.7M $90.5M 23.7% $1.5B 71/100

Frequently Asked Questions

What is WisdomTree, Inc.'s annual revenue?

WisdomTree, Inc. (WT) reported $493.8M in total revenue for fiscal year 2025. This represents a 15.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is WisdomTree, Inc.'s revenue growing?

WisdomTree, Inc. (WT) revenue grew by 15.4% year-over-year, from $427.7M to $493.8M in fiscal year 2025.

Is WisdomTree, Inc. profitable?

Yes, WisdomTree, Inc. (WT) reported a net income of $80.9M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $109.1M, with a net profit margin of 22.1%.

WisdomTree, Inc. (WT) reported diluted earnings per share of $0.75 for fiscal year 2025. This represents a 127.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

WisdomTree, Inc. (WT) had EBITDA of $178.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, WisdomTree, Inc. (WT) had $311.7M in cash and equivalents against $804.2M in long-term debt.

WisdomTree, Inc. (WT) had an operating margin of 35.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

WisdomTree, Inc. (WT) had a net profit margin of 22.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, WisdomTree, Inc. (WT) paid $0.12 per share in dividends during fiscal year 2025.

WisdomTree, Inc. (WT) has a return on equity of 26.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

WisdomTree, Inc. (WT) generated $147.7M in free cash flow during fiscal year 2025. This represents a 30.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

WisdomTree, Inc. (WT) generated $147.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

WisdomTree, Inc. (WT) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.

WisdomTree, Inc. (WT) invested $215K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, WisdomTree, Inc. (WT) spent $102.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

WisdomTree, Inc. (WT) had 142M shares outstanding as of fiscal year 2025.

WisdomTree, Inc. (WT) had a current ratio of 1.75 as of fiscal year 2025, which is generally considered healthy.

WisdomTree, Inc. (WT) had a debt-to-equity ratio of 1.94 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

WisdomTree, Inc. (WT) had a liabilities-to-equity ratio of 2.66 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

WisdomTree, Inc. (WT) had a return on assets of 7.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

WisdomTree, Inc. (WT) trades at 40.4x earnings, its market capitalization divided by $80.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

WisdomTree, Inc. (WT) trades at 5.4x sales, its market capitalization divided by $609.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

WisdomTree, Inc. (WT) has an Altman Z-Score of 2.86, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

WisdomTree, Inc. (WT) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

WisdomTree, Inc. (WT) has an earnings quality ratio of 1.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

WisdomTree, Inc. (WT) has an interest coverage ratio of 97.81x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

WisdomTree, Inc. (WT) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top